Loading insider details...
Beta
Latest Form 4 (Oct 7, 2026): Sale of 2,000 JAZZ shares, $472.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 7, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Sale | 2,000 | $472.8K |
| Sep 10, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Tax Withholding | 1,967 | $485.5K |
| Jul 2, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Tax Withholding | 4,835 | $1.15M |
| Jun 5, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Gift | 600 | n/a |
| Jun 1, 2026 | DEXCOM INC (DXCM) | Grant/Award | 5,605 | n/a |
| Mar 9, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Tax Withholding | 7,065 | $1.33M |
| Mar 2, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Grant/Award | 44,465 | n/a |
| Jan 22, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Grant/Award | 12,741 | n/a |
| Dec 9, 2025 | Jazz Pharmaceuticals plc (JAZZ) | Tax Withholding | 80 | $13.4K |
| Aug 11, 2025 | Jazz Pharmaceuticals plc (JAZZ) | Grant/Award | 18,808 | n/a |